Juárez-SaldÃvar, A.; Lara-RamÃrez, E.E.; Reyes-Espinosa, F.; Paz-González, A.D.; Villalobos-Rocha, J.C.; Rivera, G.
Ligand-Based and Structured-Based In Silico Repurposing Approaches to Predict Inhibitors of SARS-CoV-2 Mpro Protein. Sci. Pharm. 2020, 88, 54.
https://doi.org/10.3390/scipharm88040054
AMA Style
Juárez-SaldÃvar A, Lara-RamÃrez EE, Reyes-Espinosa F, Paz-González AD, Villalobos-Rocha JC, Rivera G.
Ligand-Based and Structured-Based In Silico Repurposing Approaches to Predict Inhibitors of SARS-CoV-2 Mpro Protein. Scientia Pharmaceutica. 2020; 88(4):54.
https://doi.org/10.3390/scipharm88040054
Chicago/Turabian Style
Juárez-SaldÃvar, Alfredo, Edgar E. Lara-RamÃrez, Francisco Reyes-Espinosa, Alma D. Paz-González, Juan Carlos Villalobos-Rocha, and Gildardo Rivera.
2020. "Ligand-Based and Structured-Based In Silico Repurposing Approaches to Predict Inhibitors of SARS-CoV-2 Mpro Protein" Scientia Pharmaceutica 88, no. 4: 54.
https://doi.org/10.3390/scipharm88040054
APA Style
Juárez-SaldÃvar, A., Lara-RamÃrez, E. E., Reyes-Espinosa, F., Paz-González, A. D., Villalobos-Rocha, J. C., & Rivera, G.
(2020). Ligand-Based and Structured-Based In Silico Repurposing Approaches to Predict Inhibitors of SARS-CoV-2 Mpro Protein. Scientia Pharmaceutica, 88(4), 54.
https://doi.org/10.3390/scipharm88040054